Joint Physical Activity and Cardiorespiratory Fitness: A Non-Linear Dose-Response Analysis for Cardiovascular Disease Risk Reduction

Moderate-to-vigorous physical activity (MVPA) is widely recommended for cardiovascular disease (CVD) prevention, with global guidelines advising at least 150 minutes per week. However, clinical reality shows that individuals respond differently to the same activity dose. One of the key modifiers is cardiorespiratory fitness (CRF), often estimated through maximal oxygen uptake (VO₂max).

A recent large-scale cohort and Mendelian randomisation study published in the British Journal of Sports Medicine examined how MVPA and CRF interact in shaping cardiovascular risk. The findings suggest that fitness and activity do not act independently. Instead, they form a non-linear, joint dose-response relationship that has important implications for prevention strategies in clinical practice.

Study Overview

This research combined:

• A prospective cohort analysis from the UK Biobank accelerometer dataset
• Genetic (Mendelian randomisation) analyses to explore potential causal relationships

The study included over 17,000 participants with valid accelerometer and fitness data, followed for a median of 7.85 years. During follow-up, 1,233 cardiovascular events occurred, including myocardial infarction, stroke, heart failure, and atrial fibrillation.

MVPA was measured using wrist-worn accelerometers, while CRF was estimated via a submaximal cycle test producing VO₂max estimates.

The researchers used advanced statistical modelling, including Cox generalised additive models, to evaluate how MVPA and CRF interact in shaping cardiovascular risk across continuous ranges.

Key Findings

1. MVPA and CRF interact in a non-linear way

The study found a statistically significant non-linear interaction between physical activity and fitness levels. This means that the protective effect of MVPA is not identical across all levels of CRF.

Individuals with higher fitness had a lower baseline cardiovascular risk, while those with lower fitness required more physical activity to achieve comparable risk reduction.

2. The 150-minute guideline offers modest but consistent benefit

Meeting the current guideline of 150 minutes per week of MVPA was associated with:

• Approximately 8% to 9% reduction in cardiovascular risk
• This effect was consistent across all fitness levels

This finding is clinically important because it confirms that the guideline threshold is broadly protective, even in individuals with low fitness.

However, the magnitude of benefit at this minimum level was modest compared with higher activity volumes.

3. Substantially higher activity is needed for major risk reduction

The study showed that more substantial cardiovascular protection requires significantly higher MVPA volumes:

• ~340 to 370 minutes per week for about 20% risk reduction
• ~560 to 610 minutes per week for over 30% risk reduction

This represents approximately 3 to 4 times the current minimum recommendation.

Lower-fitness individuals generally required slightly more activity than higher-fitness individuals to achieve the same relative benefit.

4. Cardiorespiratory fitness has independent prognostic value

Even after accounting for MVPA, CRF remained independently associated with cardiovascular risk:

• Each 1 mL/kg/min increase in VO₂max was associated with a 2% lower hazard of CVD
• Residual fitness beyond activity levels still conferred protection

This suggests that fitness is not just a reflection of physical activity, but also captures biological and physiological adaptations that influence cardiovascular health.

5. Genetic analyses support a role for fitness

Mendelian randomisation analyses provided supportive evidence that genetically higher CRF is associated with lower risk of heart failure. The association for physical activity traits was weaker and less consistent.

This indicates that fitness may have a more stable biological relationship with cardiovascular outcomes than activity behaviour alone, although limitations in genetic instruments for activity must be considered.

Clinical Implications for Healthcare Professionals

MVPA should remain a universal baseline recommendation

The findings strongly support continuing the 150-minute weekly MVPA guideline as a population-level target. It provides a consistent, low-barrier entry point that yields meaningful cardiovascular benefit regardless of baseline fitness.

Fitness modifies how much exercise is needed for optimal benefit

A key clinical insight is that VO₂max meaningfully stratifies how much physical activity is required for larger risk reductions. This supports a shift toward more individualised exercise prescriptions.

For example:

• Patients with low fitness may require substantially more activity to achieve similar risk reduction
• Patients with higher fitness may achieve greater relative benefit at lower doses

This supports a two-layer model:

1. Minimum guideline threshold for baseline protection
2. Higher personalised targets for optimal risk reduction

Fitness may be an underused clinical vital sign

CRF demonstrated independent predictive value beyond MVPA. This supports growing recommendations that VO₂max or estimated fitness should be incorporated into routine cardiovascular risk assessment.

In practice, this could enhance risk stratification alongside traditional markers such as blood pressure, lipid profile, and smoking status.

Potential role in preventive cardiology pathways

The study suggests that integrating wearable-derived activity data with estimated fitness metrics could support:

• Personalised risk communication
• Tailored exercise prescriptions
• Digital health interventions using real-time feedback

This aligns with emerging precision medicine approaches in lifestyle cardiology.

Limitations to Consider

While the study is methodologically strong, several limitations are important for interpretation:

• The cohort was healthier than the general population due to strict inclusion criteria
• CRF was estimated rather than directly measured with gas exchange testing
• Single time-point measurement limits understanding of long-term behavioural change
• Residual confounding cannot be fully excluded
• Genetic instruments for physical activity remain relatively weak, limiting causal inference
• The composite cardiovascular outcome combines different diseases with distinct mechanisms

These factors mean findings should be interpreted as high-quality observational evidence supported by genetic triangulation, not definitive causal proof.

Conclusion

This UK Biobank study provides strong evidence that physical activity and cardiorespiratory fitness jointly shape cardiovascular disease risk in a non-linear manner. While the widely recommended 150 minutes per week of MVPA delivers a consistent but modest protective effect, substantially greater risk reduction appears to require much higher activity volumes.

Cardiorespiratory fitness adds independent predictive value beyond activity levels, reinforcing its importance in cardiovascular risk assessment. Genetic findings further support a potential causal role for higher fitness in reducing heart failure risk.

For clinicians, the key takeaway is that current guidelines remain highly relevant as a universal baseline, but optimal cardiovascular protection may require a more individualised, fitness-informed approach to exercise prescription.

Source

• UK Biobank cohort study published in the British Journal of Sports Medicine

Disclaimer

This article is a rephrased, SEO-optimised summary intended for informational and educational purposes for healthcare professionals. It does not constitute medical advice, clinical guidance, or patient-specific recommendations. Clinical decisions should be based on full peer-reviewed publications, professional guidelines, and individual patient assessment.